Atypical Presentation of Liver Metastases of Prostate Cancer in 68Ga-PSMA-11 PET/CT.
| Autor: | Stanzel S; From the Divisions of Nuclear Medicine., Weitzer F; From the Divisions of Nuclear Medicine., Janek E; Division of General Radiology, Department of Radiology, Medical University of Graz, Graz, Austria., Plhak E; From the Divisions of Nuclear Medicine., Aigner RM; From the Divisions of Nuclear Medicine. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Clinical nuclear medicine [Clin Nucl Med] 2023 Dec 01; Vol. 48 (12), pp. 1064-1065. Date of Electronic Publication: 2023 Oct 05. |
| DOI: | 10.1097/RLU.0000000000004898 |
| Abstrakt: | Abstract: 68Ga-PSMA-11 (68Ga-prostate-specific membrane antigen-11) PET/CT continues to have a great clinical value for staging in prostate cancer. Lymph nodes and bone are the most typical metastatic sites of prostate cancer, whereas liver metastases are rare and usually show focally increased tracer uptake in 68Ga-PSMA-11 PET/CT. Here, we present an 88-year-old man with histologically proven metastatic castration-resistant prostate cancer and extensive PSMA-negative liver metastases identified by 68Ga-PSMA-11 PET/CT. This finding is remarkable because the decreased liver uptake of 68Ga-PSMA-11 may resemble a primary hepatic tumor. Competing Interests: Conflicts of interest and sources of funding: none declared. (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|